Evidence map›Paper›PMID 41944999›Full record

ReviewDermatology and therapy2026

Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy.

Maya Davis, Shelby Smith, Belle Skaggs, Kelsey Gradwohl, Julia Griffin, Melissa M Mauskar

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maya DavisMayo Clinic Alix School of Medicine, Arizona Campus, Scottsdale, AZ, USA.ORCID http://orcid.org/0000-0003-1049-6276
Shelby SmithUniversity of South Carolina School of Medicine, Columbia, SC, USA.ORCID http://orcid.org/0000-0002-2755-5108
Belle SkaggsTexas A&M University Naresh K. Vashisht College of Medicine, Bryan, TX, USA.
Kelsey GradwohlUniversity of Chicago, Chicago, IL, USA.
Julia GriffinDepartment of Dermatology, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0003-0586-5946
Melissa M MauskarDepartment of Dermatology, University of Texas Southwestern, 5323 Harry Hines Boulevard, MC-9190, Dallas, TX, 75390, USA. Melissa.Mauskar@utsouthwestern.edu.ORCID http://orcid.org/0000-0002-9676-0965

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy greatly impacts skin health. Patients experience both benign skin changes during these 40 weeks and exacerbations or improvements of prior dermatologic disease. Some women may also experience pregnancy-specific dermatoses that can greatly impact the health of both mother and baby. Dermatologists play a key role in the diagnosis and management of these conditions. In this comprehensive narrative review, common skin changes, dermatoses, and medication management during pregnancy are highlighted. The goal of this review is to provide clinicians with a concise, evidence-based understanding of dermatologic disease and medication management during pregnancy.

Indexed as

PregnancyPregnancy dermatosesPregnancy safetySkin changesSkin healthWomen’s health

Identifiers

PMID41944999
PMCPMC13237301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.